The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates

Journal of Pediatrics

Volumn 147, Issue 1, 2005, Pages 38-42

  Flynn, Patrick A ^a   Da Graca, Ralph L ^b   Auld, Peter A M ^b   Nesin, Mirjana ^b   Kleinman, Charles S ^b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ARTICLE; ASSAY; BEDSIDE ASSAY; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DISEASE MARKER; ECHOCARDIOGRAPHY; GESTATIONAL AGE; HUMAN; NEWBORN; NEWBORN INTENSIVE CARE; PATENT DUCTUS ARTERIOSUS; PREDICTION; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

BIOLOGICAL MARKERS; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; NATRIURETIC PEPTIDE, BRAIN; NEONATAL SCREENING; POINT-OF-CARE SYSTEMS; SENSITIVITY AND SPECIFICITY;

EID: 22144439443     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2005.03.040     Document Type: Article

References (31)

1. J.A. Kitterman, L.H. Edmunds Jr., G.A. Gregory, M.A. Heymann, W.H. Tooley, and A.M. Rudolph Patent ductus arteriosus in premature infants: incidence, relation to pulmonary disease and management N Engl J Med 287 1972 473 477
2. L.J. Krovetz, and R.D. Rowe Patent ductus, prematurity and pulmonary disease N Engl J Med 287 1972 513 514
3. P. Korhonen, O. Tammela, A.M. Koivisto, P. Laippala, and S. Ikonen Frequency and risk factors in bronchopulmonary dysplasia in a cohort of very low birth weight infants Early Hum Dev 54 1999 245 258
4. B.L. Horsley, D.B. Lerberg, A.C. Allen, J.R. Zuberbuhler, and H.T. Bahnson Respiratory distress from patent ductus arteriosus in the premature newborn Ann Surg 177 1973 806 810
5. R.W. Jones, and D. Pickering Persistent ductus arteriosus complicating the respiratory distress syndrome Arch Dis Child 52 1977 274 281
6. M.E. Milner, S.M. de la Monte, G.W. Moore, and G.M. Hutchins Risk factors for developing and dying from necrotizing enterocolitis J Pediatr Gastroenterol Nutr 5 1986 359 364
7. Y.H. Wang, B.H. Su, S.F. Wu, A.C. Chen, T.W. Lin, and H.C. Lin Clinical analysis of necrotizing enterocolitis with intestinal perforation in premature infants Acta Paediatr Taiwan 23 2002 199 203
8. N. Evans, and M. Kluckow Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants Arch Dis Child Fetal Neonatal Ed 75 1996 F183 F186
9. R.A. Mullaart, J.C. Hopman, J.J. Rotteveel, G.B. Stoelinga, A.F. De Haan, and O. Daniels Cerebral blood flow velocity and pulsation in neonatal respiratory distress syndrome and periventricular hemorrhage Pediatr Neurol 16 1997 118 125
10. P. Davis, S. Turner-Gomes, K. Cunningham, C. Way, R. Roberts, and B. Schmidt Precision and accuracy of clinical and radiological signs in premature infants at risk of patent ductus arteriosus Arch Pediatr Adolesc Med 149 1995 1136 1141
11. R.E. Swensson, L.M. Valdes-Cruz, D.J. Sahn, F.S. Sherman, K.J. Chung, and S. Scagnelli Real-time Doppler color flow mapping for detection of patent ductus arteriosus J Am Coll Cardiol 8 1986 1105 1112
12. N.H. Silverman, A.B. Lewis, M.A. Heymann, and A.M. Rudolph Echocardiographic assessment of ductus arteriosus shunt in premature infants Circulation 50 1974 821 825
13. A.E.G. Raine, P. Erne, E. Burgisser, F.B. Muller, P. Bolli, and F. Burkart Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure N Engl J Med 315 1986 533 538
14. G.S. Francis, S.R. Goldsmith, T.B. Levine, M.T. Olivari, and J.N. Cohn The neurohumoral axis in congestive heart failure Ann Intern Med 101 1984 370 377
15. G.S. Francis, C. Benedict, D.E. Johnstone, P.C. Kirlin, J. Nicklas, and C.-S. Liang Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD) Circulation 82 1990 1724 1729
16. T. Sudoh, N. Minanino, K. Kangawa, and H. Matsuo C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain Biochem Biophys Res Commun 168 1990 863 870
17. H. Yasue, M. Yoshimura, H. Sumida, K. Kikuta, K. Kugiyama, and M. Jougasaki Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1998 195 203
18. A.D. Struthers Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use? Br Med J 308 1994 1615 1619
19. S.J. Wieczorek, A.H. Wu, R. Christenson, P. Krishnaswamy, S. Gottlieb, and T. Rosano Rapid B-type natriuretic peptide assay accurately diagnosis left ventricular dysfunction and heart failure: a multicenter evaluation Am Heart J 144 2001 834 839
20. L.K. Morrison, A. Harrison, P. Krishnaswamy, R. Kazanegra, P. Clopton, and A. Maisel Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea J Am Coll Cardiol 39 2002 202 209
21. H. Schirmer, and T. Omland Circulating N-terminal pro-atrial natriuretic peptide is an independent predictor of left ventricular hypertrophy in the general population. The Tromso Study Eur Heart J 20 1999 755 763
22. H. Yamaguchi, J. Yoshida, K. Yamamoto, Y. Sakata, T. Mano, and N. Akehi Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy J Am Coll Cardiol 43 2004 55 60
23. R.G. Masters, R.A. Davies, J.P. Veinot, P.J. Hendry, S.J. Smith, and A.J. de Bold Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans Circulation 100 1999 287 291
24. R. Berger, M. Huelsman, K. Strecker, A. Bojic, P. Moser, and B. Stanek B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 2002 2392 2397
25. A. Koch, and H. Singer Normal values of B-type natriuretic peptide in infants, children, and adolescents Heart 89 2003 875 878
26. T.S. Mir, R. Laux, H.H. Hellwege, B. Liedke, C. Heinse, and H. von Buelow Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal probrain natriuretic peptide in healthy neonates: marked and rapid increase after birth Pediatrics 112 2003 896 899
27. H. Holmstrom, C. Hall, and E. Thaulow Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants Acta Paediatr 90 2001 184 191
28. V.F. Puddy, C. Amirmansour, A.F. Williams, and D.R. Singer Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants Clin Sci (Lond) 103 2002 75 77
29. G. Tjeerdsma, R.A. deBoer, F. Boomsma, M.P. van den Berg, Y.M. Pinto, and D.J. van Veldhuisen Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure Int J Cardiol 86 2002 143 149
30. M.R. Cowie, P.K. Jourdain, A. Maisel, U. Dahlstrom, F. Follath, and R. Isnard Clinical applications of B-type natriuretic peptide (BNP) testing Eur Heart J 24 2003 1710 1718
31. B. Bozkurt, and D.L. Mann Use of biomarkers in the management of heart failure: are we there yet? Circulation 107 2003 1231 1233